These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 7557568

  • 21. Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy.
    Bodger K, Wyatt JI, Heatley RV.
    Helicobacter; 2001 Sep; 6(3):216-24. PubMed ID: 11683924
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. High prevalence of serum immunoglobulin G antibody to Helicobacter pylori and raised serum gastrin and pepsinogen levels in enlarged fold gastritis.
    Yasunaga Y, Bonilla-Palacios JJ, Shinomura Y, Kanayama S, Miyazaki Y, Matsuzawa Y.
    Can J Gastroenterol; 1997 Sep; 11(5):433-6. PubMed ID: 9286479
    [Abstract] [Full Text] [Related]

  • 27. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C, Bölükbaş FF, Ovünç O, Kiliç G, Dalay R, Güven H, Uras F, Yardimci TK, Sökmen MH, Agan AF, Pişkinpaşa N.
    Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
    [Abstract] [Full Text] [Related]

  • 28. Helicobacter pylori, dietary factors, and atrophic gastritis in five Japanese populations with different gastric cancer mortality.
    Tsugane S, Kabuto M, Imai H, Gey F, Tei Y, Hanaoka T, Sugano K, Watanabe S.
    Cancer Causes Control; 1993 Jul; 4(4):297-305. PubMed ID: 8347778
    [Abstract] [Full Text] [Related]

  • 29. Role of anti-parietal cell antibody in Helicobacter pylori-associated atrophic gastritis: evaluation in a country of high prevalence of atrophic gastritis.
    Ito M, Haruma K, Kaya S, Kamada T, Kim S, Sasaki A, Sumii M, Tanaka S, Yoshihara M, Chayama K.
    Scand J Gastroenterol; 2002 Mar; 37(3):287-93. PubMed ID: 11916190
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori.
    Ricci C, Vakil N, Rugge M, Gatta L, Perna F, Osborn JF, Russo VM, Tampieri A, Bernabucci V, Miglioli M, Vaira D.
    Am J Gastroenterol; 2004 Oct; 99(10):1910-5. PubMed ID: 15447749
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis.
    Sitas F, Smallwood R, Jewell D, Millard PR, Newell DG, Meuwissen SG, Moses S, Zwiers A, Forman D.
    Cancer Epidemiol Biomarkers Prev; 1993 Oct; 2(2):119-23. PubMed ID: 8467246
    [Abstract] [Full Text] [Related]

  • 34. Changes in serum pepsinogen, gastrin, and immunoglobulin G antibody titers in helicobacter pylori-positive gastric ulcer after eradication of infection.
    Ohkusa T, Takashimizu I, Fujiki K, Araki A, Honda K, Shimoi K, Sakurazawa T, Horiuchi T, Suzuki S, Ariake K, Ishii K.
    J Clin Gastroenterol; 1997 Jul; 25(1):317-22. PubMed ID: 9412911
    [Abstract] [Full Text] [Related]

  • 35. Risk factors of peptic ulcer disease: different impact of Helicobacter pylori in Dutch and Japanese populations?
    Schlemper RJ, van der Werf SD, Vandenbroucke JP, Biemond I, Lamers CB.
    J Gastroenterol Hepatol; 1996 Sep; 11(9):825-31. PubMed ID: 8889960
    [Abstract] [Full Text] [Related]

  • 36. [Serological diagnosis of atrophic gastritis with a combination of pepsinogen I and II, gastrin-17 and anti-Helicobacter pylori antibodies].
    Valle Muñoz J, Artaza Varasa T, López Pardo R, Rodríguez Merlo R, Pérez Grueso MJ, Martín Escobedo R, Alcántara Torres M, Cuena Boy R, Carrobles Jiménez JM.
    Gastroenterol Hepatol; 2007 Dec; 30(10):567-71. PubMed ID: 18028850
    [Abstract] [Full Text] [Related]

  • 37. No association between AICDA 7888 C/T polymorphism, Helicobacter pylori seropositivity, and the risk of atrophic gastritis and gastric cancer in Japanese.
    Hishida A, Matsuo K, Goto Y, Mitsuda Y, Hiraki A, Naito M, Wakai K, Tajima K, Hamajima N.
    Gastric Cancer; 2010 Mar; 13(1):43-9. PubMed ID: 20373075
    [Abstract] [Full Text] [Related]

  • 38. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
    Maconi G, Lazzaroni M, Sangaletti O, Bargiggia S, Vago L, Bianchi Porro G.
    Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
    [Abstract] [Full Text] [Related]

  • 39. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis.
    Zagari RM, Rabitti S, Greenwood DC, Eusebi LH, Vestito A, Bazzoli F.
    Aliment Pharmacol Ther; 2017 Oct; 46(7):657-667. PubMed ID: 28782119
    [Abstract] [Full Text] [Related]

  • 40. Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control study.
    Monkemuller K, Neumann H, Nocon M, Vieth M, Labenz J, Willich SN, Stolte M, Hocker M, Jaspersen D, Lind T, Malfertheiner P.
    Aliment Pharmacol Ther; 2008 Aug 15; 28(4):491-6. PubMed ID: 18557987
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.